Anika Therapeutics (ANIK)

Cash burn rate (est.)	Burn method: Change in cash		Burn method: Operating income		Burn method: FCF (opex + capex)
	Last Q	Avg 4Q	Last Q	Avg 4Q	Last Q	Avg 4Q
Cash on hand (at last report)	62.37 mm	62.37 mm	62.37 mm	62.37 mm	62.37 mm	62.37 mm
Cash burn (monthly)	151.33 k	690.25 k	9.34 mm	8.01 mm	(no burn)	(no burn)
Cash used (since last report)	608.71 k	2.78 mm	37.56 mm	32.21 mm	n/a	n/a
Cash remaining	61.76 mm	59.59 mm	24.80 mm	30.15 mm	n/a	n/a
Runway (months of cash)	408.1	86.3	2.7	3.8	n/a	n/a

Beta Read what these cash burn values mean

Financial data from company earnings reports.

Institutional ownership, Q3 2024

ANIK institutional ownership history Ownership history

89.4% owned by funds/institutions

13F holders	Current	Prev Q	Change
Total holders	122	114	+7.0%
Opened positions	15	14	+7.1%
Closed positions	7	16	-56.3%
Increased positions	34	38	-10.5%
Reduced positions	49	48	+2.1%

13F shares	Current	Prev Q	Change
Total value	309.68 bn	318.87 bn	-2.9%
Total shares	13.09 mm	13.24 mm	-1.1%
Total puts	100.00	5.00 k	-98.0%
Total calls	200.00	2.70 k	-92.6%
Total put/call ratio	0.5	1.9	-73.0%

Largest owners	Shares	Value	Change
Trigran Investments	2.12 mm	$52.47 bn	-0.6%
BlackRock	1.76 mm	$43.59 bn	NEW
Caligan Partners	1.44 mm	$35.45 bn	-0.1%
Vanguard	798.64 k	$19.73 bn	+1.1%
Dimensional Fund Advisors	707.37 k	$17.47 bn	-5.6%
Renaissance Technologies	574.23 k	$14.18 bn	-4.0%
Boothbay Fund Management	503.84 k	$12.44 bn	+0.4%
MS Morgan Stanley	452.98 k	$11.19 bn	-9.8%
Acadian Asset Management	448.78 k	$11.08 mm	+1.3%
Geode Capital Management	324.96 k	$8.03 bn	-4.7%

Largest transactions	Shares	Bought/sold	Change
BlackRock	1.76 mm	+1.76 mm	NEW
BLK BlackRock	0.00	-1.61 mm	EXIT
Riverwater Partners	102.00 k	+86.04 k	+539.1%
Aqr Capital Management	30.69 k	-76.68 k	-71.4%
Nuveen Asset Management	41.32 k	-58.76 k	-58.7%
MS Morgan Stanley	452.98 k	-49.01 k	-9.8%
Citadel Advisors	42.07 k	-47.06 k	-52.8%
Virtus Investment Advisers	0.00	-45.58 k	EXIT
Dimensional Fund Advisors	707.37 k	-41.92 k	-5.6%
Capital Management	290.35 k	-38.27 k	-11.6%

Data from 13F filings, for the last complete 13F reporting period. For most recent data, click the ownership history button. Values as filed, not updated for current price. Long positions only.

Recent insider trades

ANIK insider ownership history Insider history

Date	Owner	Security	Transaction	Code	Indirect	10b5-1	$Price	#Shares	$Value	#Remaining
1 Oct 24	Anne Nunes	Common Stock	Payment of exercise	Dispose F	No	No	24.27	732	17.77 k	13,479
1 Oct 24	Anne Nunes	Common Stock	Option exercise	Acquire M	No	No	0	2,491	0.00	14,211
1 Oct 24	Anne Nunes	RSU Common Stock	Option exercise	Dispose M	No	No	0	2,491	0.00	0
9 Jul 24	Gary P Fishetti	Common Stock	Grant	Acquire A	No	No	0	5,771	0.00	27,449
9 Jul 24	Glenn R. Larsen	Common Stock	Grant	Acquire A	No	No	0	5,771	0.00	36,094
9 Jul 24	Susan L N Vogt	Common Stock	Grant	Acquire A	No	No	0	5,771	0.00	36,049
9 Jul 24	Capper Joseph H	Common Stock	Grant	Acquire A	No	No	0	5,771	0.00	6,239

Data from 3, 4 and 5 filings. Values as filed, not updated for current price.

Press releases

From Benzinga Pro

Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference

23 Dec 24

BEDFORD, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ:ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl Blanchard, President and

Sidoti Events, LLC's Virtual December Small-Cap Conference

3 Dec 24

NEW YORK, NY / ACCESSWIRE / December 3, 2024 / Sidoti Events, LLC, an affiliate of Sidoti & Company, LLC, has released the presentation schedule and weblinks for its two-day December Small-Cap Conference taking place

Anika To Participate in December 2024 Investor Conferences

22 Nov 24

BEDFORD, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ:ANIK), a global joint preservation company in early intervention orthopedics, today announced that senior management will participate